KELLY CRAGETT- KNOWLES: Open Payments
NPI 1710483771 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,515 in 69 payments from 28 companies in 2025. Trend: 2023 $1,186 · 2024 $1,152 · 2025 $1,515
Food & beverage: $1,515
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $118 |
| GlaxoSmithKline, LLC. | 5 | $114 |
| AstraZeneca Pharmaceuticals LP | 5 | $113 |
| Daiichi Sankyo Inc. | 4 | $103 |
| ABBVIE INC. | 4 | $94 |
| Gilead Sciences, Inc. | 3 | $61 |
| ARRAY BIOPHARMA INC | 3 | $59 |
| Celgene Corporation | 2 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
Products named: ENHERTU, TECVAYLI, OJJAARA, Trodelvy, LORBRENA, REBLOZYL, OPDIVO, ALUNBRIG.
Industry payments across FL — which companies pay providers there.
